Correction to: Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation

Cancer Chemother Pharmacol. 2020 Jan;85(1):237-239. doi: 10.1007/s00280-019-03984-2.

Abstract

In the original publication of the article, the authors found few errors and the corrections are given below.

Publication types

  • Published Erratum